Back to mobile site

Nomura/Instinet Reiterates Neutral Rating on Gland Pharma Ltd (GLAND:IN)

May 23, 2024 12:50 AM EDT Send to a Friend
Nomura/Instinet analyst Saion Mukherjee reiterated a Neutral rating and INR1,570.00 price target on Gland Pharma Ltd (GLAND:IN).The analyst comments: "Gland’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login